MCDS-Therapy isn't just a clinical trial. It is a pioneering, investigator-led, EU-funded, international, drug repurposing and rare disease clinical trial.
We are so proud of everything we're doing that we're spreading the word far and wide. Earlier in June, Rick Thompson, from our partner Findacure, and Ronny Schmidt, from our partner Sciomics, travelled over to Berlin for a SPARK conference. Here they talked with academic researchers about the challenges and opportunities around repurposing drugs for rare diseases.
If you represent an academic body and would like to find out more about speaking opportunities, please do get in touch: email@example.com.